Yestar Healthcare Announces Leadership Changes
Yestar Healthcare Holdings Co Ltd (HK:2393) has announced leadership changes effective April 2, 2025. Mr. Wang Chunlai will become an executive director, while Ms. Liao Changxiang resigns as CEO to become general manager for Guangxi operations. These changes are part of a succession plan to enhance management and operational focus. Yestar operates in the healthcare sector, with a significant presence in Shanghai and Guangxi. Current market cap is HK$237.6M, with a year-to-date price performance of 50.0%.
Yestar Healthcare Holdings Co Ltd ( (HK:2393) ) has shared an update.
Yestar Healthcare Holdings Co Ltd has announced key leadership changes effective April 2, 2025. Mr. Wang Chunlai has been appointed as an executive director, bringing extensive experience within the company since 2000. Concurrently, Ms. Liao Changxiang has resigned as CEO and member of the investment committee, transitioning to a general manager role for the Guangxi operations. These changes are part of a succession plan aimed at strengthening the company’s management structure and operational focus.
More about Yestar Healthcare Holdings Co Ltd
Yestar Healthcare Holdings Co Ltd is a company incorporated in the Cayman Islands, operating in the healthcare sector. The company, along with its subsidiaries, focuses on healthcare technology and services, with a significant presence in Shanghai and Guangxi through its subsidiary Yestar Shanghai.
YTD Price Performance: 50.0%
Average Trading Volume: 3,011,336
Technical Sentiment Signal: Hold
Current Market Cap: HK$237.6M
Learn more about 2393 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- Walmart (WMT) Urges Chinese Suppliers to Lower Prices on Rising Tariff Tensions
- Visa Makes a $100M Bid to Oust Rival Mastercard from Apple’s Card Network
- ‘Don’t Pull the Trigger Just Yet,’ Says Investor About Archer Aviation Stock
Disclaimer & DisclosureReport an Issue
